Poseida Therapeutics, Inc.
New Filing
CIK: 0001661460·Biotechnology·DELAWARE·Filed: Apr 22, 2019
Total Offering
$150,000,000
Amount Sold
$142,120,007
Investors
17
First Sale
Mar 19, 2019
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2014
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Eric Ostertag | Related Person |
| Mark Gergen | Related Person |
| Matthew Spear | Related Person |
| David Hirsch | Related Person |
| Marcea Bland Lloyd | Related Person |
| Catherine J. Mackey | Related Person |
| Sean Murphy | Related Person |
| John Schmid | Related Person |
| Noah Berkowitz | Related Person |
Company
SEC Filing
0001661460-19-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free